Guardant Health Inc. Common Stock vs SPDR Kensho Final Frontiers ETF — how do they compare? Guardant Health Inc. Common Stock trades at $168.44 (market cap $22.22B), while SPDR Kensho Final Frontiers ETF trades at $102.69 (market cap $170.14M). The key difference: Guardant Health Inc. Common Stock is far larger — about 130.6× SPDR Kensho Final Frontiers ETF's market cap, and Guardant Health Inc. Common Stock is trading nearer its 52-week high, SPDR Kensho Final Frontiers ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 0 Days and SPDR Kensho Final Frontiers ETF for 8 Days on average.
| GH | ROKT | |
|---|---|---|
Market Cap | $22.22B | $170.14M |
Volume | 1,589,453 | 12,298 |
Sector | Health | Sector/Thematic |
52-Week High | $187.22 | $136.68 |
52-Week Low | $61.73 | $72.93 |
Typical Hold Time | 0 Days | 8 Days |
Enterprise Value | $22.86B | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →SPDR Kensho Final Frontiers ETF seeks exposure to companies supporting exploration of outer space and the deep sea. Its holdings include businesses involved in aerospace, defense, communications, research, and related technologies.
Read more on ROKT →